StonvexLoading…
StonvexStonvexStonvexCore line items from EOG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $6.92B | $22.63B | $16.99B | $11.15B |
Operating Income | $2.60B | $6.38B | $5.44B | $3.61B |
Net Income | $1.98B | $4.98B | $4.28B | $2.81B |
EPS (Diluted) | $3.70 | $9.12 | $7.81 | $5.11 |
Total Assets | $53.38B | $51.80B | $52.20B | $46.28B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $3.85B | $3.40B | $3.53B | $5.22B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 535.00M | 546.00M | 548.00M | 549.00M |